Norman E. Sharpless, MD (IMAGE)
Caption
Lagging federal funding of trials will reduce critical research in areas like cancer prevention, screening, symptom management and health disparities, said Norman E. Sharpless, MD, UNC Lineberger member and professor of cancer policy and innovation at UNC School of Medicine. “To sustain progress and address these gaps, we need diversified funding and strong advocacy to ensure that all patient populations benefit from research advancements.”
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content